Sakar Healthcare Limited — Important, 24-02-2025: General Updates

Sakar Healthcare Limited has initiated a technology transfer for seven registered oncology products to supply Accord Healthcare Limited in the UK, EU, and emerging markets. This strategic partnership is expected to enhance Sakar's oncology product offerings, including both injections and oral solids, leveraging their EU GMP-approved manufacturing capabilities. Accord Healthcare, recognized as a leading player in the oncology sector within the EU, operates in over 45 countries, focusing on generic anti-cancer medicines for hospitals and retail pharmacies. This collaboration signifies a positive outlook for Sakar's export potential and strengthens its position in the oncology market. Investors should monitor this development closely as it may lead to increased revenues and market penetration.